Author: openjargon

  • How much passive income would I make from 200 NAB shares?

    Woman in a hammock relaxing, symbolising passive income.

    Owning National Australia Bank Ltd (ASX: NAB) shares has been pleasing when it comes to receiving passive income in the form of dividends.

    The ASX bank share sector collectively has quite a high dividend payout ratio, which pushes up the dividend yield. The other side to the equation is having a reasonable price/earnings (P/E) ratio.

    The NAB share price has risen strongly over the past year, as we can see in the chart below.

    After the bank’s recent release of the FY24 first-half result, let’s consider how big the dividend payouts might be in the future.

    HY24 payout recap

    NAB reported that its cash earnings of $3.55 billion for the six months to 31 March 2024 were down 12.8% year over year and down 3.1% half-on-half.

    However, the diluted cash earnings per share (EPS) of $1.12 didn’t drop as much – it fell 1.6% half-on-half and 12.3% year on year.

    NAB decided to grow its interim dividend per share by 1.2% year over year to 84 cents per share. This was the same dividend as the FY23 second-half dividend. It represents a cash dividend payout ratio of 75%, which is generous and leaves some profit within the business for more growth.

    That means the business currently has a fully franked dividend yield of around 5% and a grossed-up dividend yield of approximately 7%.

    How much passive income would 200 NAB shares pay?

    If NAB were to repeat the last two declared dividends as the next two dividends, it would be an annual payout of $1.68. Owning 200 NAB shares would mean receiving $336 of cash and $480 of grossed-up dividends if we include the franking credits.

    But that’s assuming the dividends don’t change in the coming years. Some analysts think the NAB dividend may grow in the next few years.

    The estimate on Commsec suggests the bank could pay a passive income of $1.70 per share in FY25 and $1.71 per share in FY26.

    That means that if an investor owned 200 NAB shares, it could pay $340 in cash dividends and $486 in grossed-up dividends, with the franking credits as a bonus.

    Outlook for NAB shares

    The NAB dividend could be heavily influenced by how the economy performs for the foreseeable future. NAB had this to say regarding the economic outlook:

    In Australia, household consumption growth slowed sharply in the second half of 2023, impacted by interest rates and cost of living pressures. This is weighing on real GDP growth which is expected to remain below-trend over the near term.

    However, some relief is anticipated later this year with expected tax cuts and a forecast easing in monetary policy from November should inflation continue to moderate. Following 1.5% GDP growth over 2023, growth of 1.7% is forecast over 2024, before improving to around 2.25 % in 2025.

    Pressure has eased in the labour market and wage growth is expected to slow from elevated rates in 2023. The unemployment rate is expected to continue to drift higher, peaking at around 4.5% by end 2024, but most indicators of labour demand remain healthy suggesting employment will continue to grow.

    The post How much passive income would I make from 200 NAB shares? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    (function() {
    function setButtonColorDefaults(param, property, defaultValue) {
    if( !param || !param.includes(‘#’)) {
    var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
    button.style[property] = defaultValue;
    }
    }

    setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
    setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
    setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
    })()

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • We asked a parasite expert about RFK Jr.’s claim that a worm ate his brain. Here’s what they said.

    Robert F. Kennedy Jr.'s claim that a worm ate his brain is most likely not accurate, a parasite expert told BI.
    Robert F. Kennedy Jr.'s claim that a worm ate his brain is most likely not accurate, a parasite expert told BI.

    • Did a worm eat Robert F. Kennedy Jr.'s brain?
    • The third-party presidential candidate said in a 2012 deposition that a doctor suggested a parasite hurt him.
    • We spoke to an expert, who said a brain-eating tapeworm larvae would be impossible.

    Brain-eating worms? Not likely.

    A shocking report in The New York Times on Wednesday revealed that independent presidential candidate Robert F. Kennedy Jr. suggested in a 2012 deposition that doctors had found a dead worm in his brain.

    In the court proceeding — part of his divorce from his second wife — Kennedy said that he had short-term and long-term memory loss, according to The Times.

    Kennedy said he had visited doctors in 2010 who thought he had a brain tumor, but another doctor suggested that a dark spot on Kennedy's brain scan was "caused by a worm that got into my brain and ate a portion of it and then died," The Times reported.

    Kennedy argued in the deposition that he couldn't make as much money due to his health, and also revealed that he had mercury poisoning around the same time.

    Kennedy has portrayed himself as the younger, more healthy alternative to the other two men running for president, Joe Biden and Donald Trump.

    His campaign's press secretary confirmed that Kennedy was infected with a parasite 10 years ago and said it was resolved. His campaign told Business Insider that Kennedy is in "robust physical and mental health" and said questioning his fitness is a "hilarious suggestion, given his competition."

    But could a parasitic worm even cause that kind of damage? One medical expert told Business Insider that Kennedy's version of events doesn't quite add up.

    Dr. Janina Caira, a University of Connecticut professor and tapeworm specialist, told BI that Kennedy's parasite sounds more like the larvae of a pork tapeworm.

    That would be rare, Caira said in an email. Humans can be infected with the adult worm by eating undercooked pork, but can only be infected with the larvae after eating food or drinking water contaminated by the feces of someone with an adult tapeworm infection.

    "This typically happens in areas with poor sanitation," Caira said. "So, it is possible that he could have contracted the infection in South Asia if he came into contact with food or water contaminated with eggs of the tapeworm."

    But there's no way the larvae could have consumed Kennedy's brain tissue.

    "Absolutely not," Caira wrote. 

    She said the larvae don't have mouths or digestive systems. Instead, they absorb nutrients through the surface of their bodies. While Caira said it is possible that a worm could do some "mechanical damage" to nearby brain tissue, the larvae are very small, and a single one "would not cause much damage."

    That lines up with what experts, who were skeptical of the details, told The New York Times.

    However, Dr. Peter Hotez, a pediatrician and global health advocate who is a professor of pediatrics and molecular virology & microbiology at Baylor College of Medicine, wrote on X that "neuroparasitic diseases" and "parasitic worms have a huge impact on the human brain."

    Hotez said the diseases are seen in poor populations, with a "surprising amount of illness" in southern states and Texas. He said his team at the National School of Tropical Medicine is working on low-cost vaccines to prevent the conditions.

    Read the original article on Business Insider
  • 2 magnificent ASX dividend shares I’ll be buying more of in May

    A baby reaches into the bottom drawer of a chest of drawers.

    Rather than ‘sell in May and go away’, I like to ‘buy while the cash is cold and hold’ — there has to be something catchier… nevertheless, the point still stands. No old saying will prevent me from pulling the trigger on buying if there are looming opportunities in the market.

    The fight against inflation waged by the Reserve Bank of Australia continues to threaten a ‘genuine’ recession. Warren Buffett recently said the investment landscape isn’t ‘attractive’. And I haven’t purchased any individual shares since February… that’s bearish, right?

    I don’t think so.

    It might mean those no-brainer buys are harder to find, but I reckon a keen-eyed investor can spot a beauty even now.

    Why buy ASX dividend shares?

    I try not to place too much emphasis on income in my portfolio. While still in my younger years, my goal is to maximise wealth growth. Hence, I’m not looking for companies with the highest dividend yield, trying to squeeze out every last dollar I can to fund my next year of activities.

    However, if I can find a great quality company that just happens to pay dividends… That’s the investing equivalent of finding loose chips in the bottom of the Maccas bag after devouring your fries. You weren’t expecting it, but you’re glad to see them.

    After a while, those dividends add up. I’ve purchased other ASX shares with money solely sourced from dividends. It feels like I’ve stumbled upon some sort of money glitch. Whatever ‘math’ you want to call it, investments funded by income from ASX dividend shares are pretty magical.

    I’ve prattled on long enough. Here’s what I’m buying this month.

    My bottom drawer buy

    It mightn’t be a dividend aristocrat, but it’s close enough for me. Sonic Healthcare Ltd (ASX: SHL) has steadily grown its dividends for 30 years. That’s worthy of some sort of term. Maybe dividend stalwart is fitting.

    The laboratory, pathology, and radiology services provider is a cornerstone of healthcare systems worldwide. However, investors have sold down the stock by more than 40% from its all-time high as COVID testing revenues have evaporated.

    In my view, the market is overlooking the quality of Sonic’s base business. Pathology and laboratory testing is a difficult industry to crack. The value typically accrues to the players with the greatest scale — that’s what Sonic Healthcare is in multiple markets.

    Due to the sell-off, this ASX dividend share is currently trading on a dividend yield of 4%.

    Pouncing on the pullback

    Macquarie Group Ltd (ASX: MQG) posted a lacklustre full-year result last week. Net profit for the 12-month period was down 32% versus the prior year, prompting the financial dynamo to dial back its final dividend by 14.4% to $3.85 per share.

    The Macquarie share price is now roughly 5% below its 52-week high.

    At first glance, the result appears worthy of selling. But let’s not be hasty.

    I believe Macquarie will still be a frontrunner in the long term. The company houses an immense array of expertise in funding and managing infrastructure. Such skills could be in high demand over the coming decades.

    This ASX dividend share is yielding 3.4%.

    The post 2 magnificent ASX dividend shares I’ll be buying more of in May appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    (function() {
    function setButtonColorDefaults(param, property, defaultValue) {
    if( !param || !param.includes(‘#’)) {
    var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
    button.style[property] = defaultValue;
    }
    }

    setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
    setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
    setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
    })()

    More reading

    Motley Fool contributor Mitchell Lawler has positions in Macquarie Group and Sonic Healthcare. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • How counterfeit Rolexes are produced and distributed, according to an investigator

    Rob Holmes is a private investigator. He works with major luxury-watch brands to track down fakes and stop them from getting to market.

    Holmes speaks with Business Insider about how counterfeits are made in factories overseas. He gives details about how fake luxury goods are trafficked into the United States and distributed to consumers, tells us how the counterfeit industry has evolved with the rise of a new generation of "superfakes," and gives advice about how to spot a counterfeit. He also examines a genuine Rolex and gives tips on how to spot a genuine watch.

    Holmes began investigating counterfeits during his childhood: His father, Rob Sr., was a renowned counterfeit investigator in New York in the 1980s. Holmes describes his dad's encounters with Chinatown gangs and tells Business Insider how he and his brother are carrying on their father's legacy through their investigations business, MI:33.

    Find out more:

    https://linktr.ee/holmespi

    https://mi33.co/

    Read the original article on Business Insider
  • 5 things to watch on the ASX 200 on Thursday

    A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought

    On Wednesday, the S&P/ASX 200 Index (ASX: XJO) continued its winning run and pushed higher. The benchmark index rose 0.15% to 7,804.5 points.

    Will the market be able to build on this on Thursday? Here are five things to watch:

    ASX 200 expected to fall

    The Australian share market looks set for a subdued session on Thursday following a mixed night on Wall Street. According to the latest SPI futures, the ASX 200 is expected to open the day 16 points or 0.2% lower this morning. In the United States, the Dow Jones was up 0.45%, but the S&P 500 was flat and the Nasdaq fell 0.2%.

    Oil prices rise

    ASX 200 energy shares including Beach Energy Ltd (ASX: BPT) and Woodside Energy Group Ltd (ASX: WDS) could have a good session after oil prices charged higher overnight. According to Bloomberg, the WTI crude oil price is up 1.1% to US$79.22 a barrel and the Brent crude oil price is up 0.7% to US$83.77 a barrel. This was driven by a surprise stockpile decline in the United States.

    CBA Q3 update

    The Commonwealth Bank of Australia (ASX: CBA) share price will be on watch on Thursday when the banking giant releases its third quarter update. One area of focus for investors will be productivity. Goldman Sachs recently commented: “In light of the soft revenue growth environment, it has become increasingly important for the sector to take a more proactive approach in cost management. Adding to this challenge has been stickier than expected inflation which was a headwind to costs in FY23 with its impact broadly based across i) staff, ii) third party, iii) and investment spend. Overall we are of the view the key to offsetting these inflationary pressures will be the banks’ ability to deliver productivity improvements.”

    Gold price softens

    It looks set to be a subdued day for ASX 200 gold shares Newmont Corporation (ASX: NEM) and Northern Star Resources Ltd (ASX: NST) after the gold price softened overnight. According to CNBC, the spot gold price is down 0.3% to US$2,316.4 an ounce. The precious metal appears to be in a holding pattern while waiting for rate cut clues.

    Westpac goes ex-dividend

    Westpac Banking Corp (ASX: WBC) shares are going ex-dividend on Thursday and look likely to drop into the red. Earlier this week, Australia’s oldest bank released its half year results and posted a 4% year on year decline in net operating income to $10,590 million. However, this couldn’t stop the bank from increasing its fully franked interim dividend by 7.1% to 75 cents per share and declaring a special fully franked 15 cents per share dividend. These dividends will be paid to eligible shareholders on 25 June.

    The post 5 things to watch on the ASX 200 on Thursday appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    (function() {
    function setButtonColorDefaults(param, property, defaultValue) {
    if( !param || !param.includes(‘#’)) {
    var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
    button.style[property] = defaultValue;
    }
    }

    setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
    setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
    setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
    })()

    More reading

    Motley Fool contributor James Mickleboro has positions in Westpac Banking Corporation and Woodside Energy Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Aussie investors: 3 ASX shares to buy and hold forever

    a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today

    I think that buy and hold investing with ASX shares is one of the best ways to grow wealth.

    Let me now demonstrate why.

    Buy and hold ASX shares

    Over the long term, the share market has delivered investors an average annual return of 10% per annum.

    And while there is no guarantee that it will continue doing the same in the future, we’re going to assume that it does for the purpose of this article.

    Based on that return, if you are able to invest $10,000 into ASX shares each year and earned the market return, you would grow your portfolio to $175,000 after 10 years thanks to the power of compounding.

    But why stop there? Compounding really starts to work its magic the longer you leave it. So, if we fast forward another 10 years of doing the same, your portfolio would have become worth almost $650,000.

    But which ASX shares would be good options for a buy and hold investment? Three to consider are as follows:

    CSL Ltd (ASX: CSL)

    The first ASX share that could be a great buy and hold option is CSL.

    It is the biotechnology giant behind the CSL Behring, CSL Vifor, and CSL Seqirus businesses. These are leaders in their respective fields and provide world-class plasma therapies, iron deficiency and nephrology treatments, and vaccines.

    UBS thinks investors should be buying its shares at present. The broker currently has a buy rating and $330.00 price target on CSL’s shares.

    Nextdc Ltd (ASX: NXT)

    Another ASX share that could be a great long term option for investors right now is NextDC.

    It is a leading data centre operator with world class operations across the Asia Pacific. Thanks to the shift to the cloud and the artificial intelligence boom, demand for data centre capacity is growing rapidly. This has many analysts predicting that NextDC will grow its earnings very strongly over the next decade.

    One of those is Morgans, which has an add rating and $19.00 price target on its shares.

    Pro Medicus Limited (ASX: PME)

    Finally, this health imaging technology company could be a quality option for investors.

    It is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualisation solutions across the globe.

    Goldman Sachs is very bullish on the company’s long term outlook. So much so, it recently put a buy rating and $134.00 price target on its shares.

    The post Aussie investors: 3 ASX shares to buy and hold forever appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    (function() {
    function setButtonColorDefaults(param, property, defaultValue) {
    if( !param || !param.includes(‘#’)) {
    var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
    button.style[property] = defaultValue;
    }
    }

    setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
    setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
    setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
    })()

    More reading

    Motley Fool contributor James Mickleboro has positions in CSL, Nextdc, and Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goldman Sachs Group, and Pro Medicus. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Is Wesfarmers stock a good long-term investment?

    Three happy shoppers.

    Through the Australian share market, we can buy passive interests in a diversified set of operations via a single investment.

    With an investment in Wesfarmers Ltd (ASX: WES) stock, we have just that. The holding company boasts a portfolio containing some of Australia’s strongest retail, healthcare, and chemicals brands.

    These include Bunnings, Kmart/Target, Officeworks, Priceline Pharmacy, and Flybuys just to name a select few. When you own Wesfarmers stock, you own pieces of these companies, too.

    Wesfarmers has a long history of creating value for its shareholders. Its share price is up 81% since May 2019. A $10,000 investment back then is now worth $18,100, plus $1,667 in dividends.

    But what about the future? Here, I’ll explain.

    Diversification: Good for risk and value

    One major reason for Wesfarmers’ success is its highly diversified operations. Most people think of diversification as spreading their risk across a number of assets.

    But diversification also provides many sources of value. Wesfarmers has 37 brands operating under its wings. It has fingers in many pies.

    Goldman Sachs touched on this in a recent note, stating many Wesfarmers’ divisions remained “under-appreciated by the market”, including digital, retail media and the WES health platform.

    Goldman also expects a respective 6% and 11% growth in sales and earnings before interest and tax (EBIT) for the Bunnings franchise in FY 2025/2026.

    This could generate “strong annual free cash flow of $2.5 billion–$3 billion to fund two new high-growth and high-return platforms, Health and Lithium…”.

    These are two points to take note of.

    Speaking of Bunnings and Kmart

    Wesfarmers’ portfolio is filled with low profit margin, high sales volume companies. They have wide consumer penetration, as a result.

    Goldman cited volume and consumer penetration in its view on Wesfarmers stock. It said the company had the “largest volume of consumer data assets”, which included “14.2 million total loyalty members across Flybuys, Priceline and PowerPass”.

    Both Bunnings and Kmart fit this mould, too. For instance, Bunnings made up 44% of the company’s revenues in the six months to 31 December 2023 but comprised 58% of the group’s EBIT. Kmart was 22% and 29%, respectively.

    Bunnings’ H1 FY 2024 EBIT margin was 12.9%, whereas Kmart’s was 10%.  But sales volume was tremendously high — $9.9 billion and $5.9 billion respectively.

    Both companies subsequently have stellar returns of capital (ROC), tallying 66% for Bunnings and 59% for Kmart. That means every $1 Wesfarmers invests into Bunnings and Kmart returns 66 and 59 cents on that dollar, respectively. This is a competitive advantage.

    Dividends increasing

    Aside from the capital appreciation, a final tailwind for Wesfarmers is the company’s dividend. The fully franked payment of $1.94 per share gives an ungrossed dividend yield of around 2.84%, as I write.

    However, it’s the recent increase that’s worth noting.

    The company’s half-year sales growth was flat at 0.5%. But it grew net profit after tax (NPAT) by 3%. That means each $1 of new revenues brought in $6 of additional profit for the half – quite the result.

    The Wesfarmers board increased its dividend by 3.4% to $0.91 per share. Goldman Sachs sees this trend continuing through FY 2025/2026 as “cost optimising and digitalisation initiatives drive margin expansion”.

    Foolish takeaway

    Wesfarmers stock has proven to be a superb long-term investment. Based on performance, I believe it can continue to beat the S&P/ASX 200 Index (ASX: XJO) over time.

    Since January this year, the Wesfarmers share price has climbed more than 20% into the green.

    The post Is Wesfarmers stock a good long-term investment? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    (function() {
    function setButtonColorDefaults(param, property, defaultValue) {
    if( !param || !param.includes(‘#’)) {
    var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
    button.style[property] = defaultValue;
    }
    }

    setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
    setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
    setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
    })()

    More reading

    Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Wesfarmers. The Motley Fool Australia has positions in and has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • An escalating cold war between US and China would be a blow to global growth, IMF official says

    US and Chinese flags
    • A brewing US-China cold war could drag global economic growth down as much as 7%, an IMF official said this week. 
    • The emergence of "connector" countries is why the effect of ongoing tensions hasn't been bigger. 
    • Trade fragmentation carries a higher price tag compared to the US-Soviet cold war, the official said. 

    A more intense cold war between the US and China would have a potentially dire impact on the global economy, according to an official from the International Monetary Fund. 

    Speaking at Stanford University on Tuesday, IMF deputy managing director Gita Gopinath said that while US-China tensions haven't yet devolved into a full-blown cold war, such an escalation would be a major headwind to global growth. 

    The IMF predicts that the global economy could incur economic costs equivalent to as much as 7% of the world's GDP in the worst-case scenario and take a 0.2% hit to growth in milder scenarios. 

    According to the fund, lower-income countries could suffer four times the loss of economic output compared to other nations if commodity markets split into blocs aligned with either China or the US. 

    Conflict between the world's two largest economies has escalated to a new heights since the pandemic. With China's growing economic ambitions and recent aggressions against neighboring countries, the US has put up new guardrails in its dealing with China, including restricting trade in key areas both countries are racing to dominate, such as AI.

    IMF data shows that more than 3,000 trade restrictions were imposed globally in 2022 and 2023, more than triple the count from 2019, with Gopinath saying that trade within the China and US blocs has dropped compared to intra-group trade.

    The tensions have also dented flows of foreign capital to China, with the country suffering its first foreign investment deficit in November 2023 and seeing further declines in the first three months of 2024. 

    The emergence of "connector" countries, which have acted as neutral go-betweens for the US and China, may be the reason the impact of tensions hasn't been greater. 

    "The emergence of these 'connector' countries—perhaps most notably Mexico and Vietnam—may have helped cushion the global economic impact of direct trade decoupling between the U.S. and China," Gopinath said. 

    Zooming out, Gopinath highlighted that geopolitical instability in regions like the Middle East and turmoil stemming from the Russia-Ukraine war has sparked trade turbulence unseen since the Cold War. 

    The IMF emphasized that trade fragmentation carries a higher price tag today, with the goods trade-to-GDP ratio now at 45% compared to 16% at the onset of the Cold War.

    Read the original article on Business Insider
  • US Marines debuted new amphibious combat vehicle, which was previously pulled out of the water after multiple rollovers

    US Marine Corps amphibious combat vehicles conduct open water transit
    US Marine Corps amphibious combat vehicles conduct open water transit during Exercise Balikatan 24 in Palawan, Philippines.

    • The US Marines' new amphibious combat vehicle made its first overseas deployment in the Philippines.
    • US and Philippine troops conducted drills in the South China Sea to strengthen security in the region.
    • The service temporarily suspended ACV operations following multiple rollovers in 2022.

    The Marine Corps' new amphibious combat vehicle, or ACV, debuted in the Philippines as part of its first overseas deployment after more than a year-and-a-half of limited operations.

    Marines aboard ACVs launched from amphibious ships in the Pacific on Saturday to conduct live-fire training in the Philippines, the service said in a statement. The Marine unit involved in the training was the 15th Marine Expeditionary Unit, or MEU, a unit out of Camp Pendleton, California, which deployed this spring for partner exercises across the Pacific.

    The ACV was involved in multiple rollovers in 2022, which did not result in any injuries or deaths then, but the Corps temporarily pulled the vehicles from service to better train Marines in operating them. Amid the preparation for its deployment to the Pacific this year, a Marine was killed in an on-land ACV rollover incident in December.

    "The hard work and dedication of our Marines is what made today's training successful," Col. Sean Dynan, commanding officer of the 15th MEU, said in a statement Saturday. "Today's training is a proof of concept across the Marine Corps for successful ACV employment in its intended environment."

    A US Marine Corps amphibious combat vehicle splashes off the amphibious dock landing ship USS Harpers Ferry
    A US Marine Corps amphibious combat vehicle splashes off the amphibious dock landing ship USS Harpers Ferry (LSD 49) during Exercise Balikatan 24 in Palawan, Philippines.

    The deployment of the vehicle occurred during Exercise Balikatan '24, which involved US training with the Philippine military meant to build the partnership and counter Chinese influence in the region.

    A platoon of ACV Marines left the USS Harpers Ferry and attacked targets along the shore of Oyster Bay, Philippines, with MK19 grenade launchers. After wrapping up the attack, the ACVs reembarked aboard the Harpers Ferry.

    In 2022, the vehicle rolled over twice on land, which prompted the Marine Corps to pull the ACV from surf operations while it recertified crews to operate it. Late last year, a Marine with the 15th MEU, Sgt. Matthew Bylski, died after the vehicle rolled over on land during an exercise to prepare for the unit's current deployment.

    The following month, after the Corps said it had recertify its crews, the assistant commandant of the Marine Corps, Gen. Chris Mahoney, announced that the ACV was again operating in the surf and the 15th MEU would be deploying with them to the Pacific.

    US Marine Corps amphibious combat vehicles conduct a towing exercise during Exercise Balikatan 24 in Palawan, Philippines.
    US Marine Corps amphibious combat vehicles conduct a towing exercise during Exercise Balikatan 24 in Palawan, Philippines.

    The new ACVs can deploy from amphibious ships, travel across the water and take beachheads. It replaced a decades-old platform that had a troubled history, including a 2020 incident that resulted in the deaths of eight Marines and one sailor.

    That vehicle, called the amphibious assault vehicle, or AAV, had been used since the 1970s. It was lighter and had tracks, different from the wheeled ACV, which weighs roughly 70,000 pounds when fully loaded.

    The 15th MEU is deployed as part of the Boxer Amphibious Ready Group, or ARG, which includes the Harpers Ferry and USS Somerset.

    Part of the 15th MEU's deployment in April was met with trouble due to the readiness of the USS Boxer, the ARG's namesake. After suffering engineering issues, the Boxer returned to San Diego, causing Marines and sailors to be offloaded so repairs could be made.

    The Boxer had already been delayed by months, Military.com previously reported, due to maintenance issues.

    Editor's note: this story has been updated to correct the name of the amphibious combat vehicle.

    Read the original article on Business Insider
  • 2 ASX ETFs to buy and hold forever in your investment portfolio

    Man looking at an ETF diagram.

    If you are looking for an easy way to invest your hard-earned money, then exchange traded funds (ETFs) could be the answer.

    Especially if you’re just wanting to take a set and forget or buy and hold approach to investing.

    This is because ASX ETFs allow investors to buy large groups of companies in one fell swoop.

    This means you don’t have to pick individual stocks to buy, nor do you really need to keep a close eye on the companies you’re invested in. You can just put your money to work and watch your investments grow.

    But which ASX ETFs could be quality options for investors looking to make buy and hold investments? Let’s take a look at two:

    BetaShares NASDAQ 100 ETF (ASX: NDQ)

    When investing for the long term, it is never a bad idea to invest in the highest quality companies the world has to offer.

    The BetaShares NASDAQ 100 ETF certainly ticks this box. It provides investors with access to 100 of the largest non-financial companies on the famous NASDAQ index. These are the giants of Wall Street (and the world) and include iPhone maker Apple (NASDAQ: AAPL), Facebook and Instagram owner Meta (NASDAQ: META), software giant Microsoft (NASDAQ: MSFT), graphics card behemoth Nvidia (NASDAQ: NVDA), and electric vehicle leader Tesla (NASDAQ: TSLA).

    Over the last 10 years, the index this ETF tracks has delivered investors a stunning average total return of 22.25% per annum. This would have turned a $10,000 investment into almost $75,000.

    VanEck Vectors Morningstar Wide Moat ETF (ASX: MOAT)

    Another ASX ETF that could be a great buy and hold option is the VanEck Vectors Morningstar Wide Moat ETF.

    This fund has a focus on companies that are deemed to have sustainable competitive advantages (wide moats) and fair valuations.

    These are the qualities that the king of buy and hold investing, Warren Buffett, looks for when he is making investments for Berkshire Hathaway (NYSE: BRK.B).

    And given how the Oracle of Omaha has consistently outperformed the market since all the way back in 1965, I think it is fair to say that a focus on companies with wide moats and fair valuations has its merits.

    The companies that the fund invests in will change periodically. But at present it includes tobacco giant Altria Group Inc (NYSE: MO), food company Campbell Soup (NYSE: CPB), beauty products company Estee Lauder (NYSE: EL), sportswear leader Nike (NYSE: NKE), and entertainment juggernaut Walt Disney (NYSE: DIS).

    Over the past 10 years, the index the fund tracks has generated an average total return of 17.1% per annum. This would have turned a $10,000 investment into over $48,000.

    The post 2 ASX ETFs to buy and hold forever in your investment portfolio appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    (function() {
    function setButtonColorDefaults(param, property, defaultValue) {
    if( !param || !param.includes(‘#’)) {
    var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
    button.style[property] = defaultValue;
    }
    }

    setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
    setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
    setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
    })()

    More reading

    Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool’s board of directors. Motley Fool contributor James Mickleboro has positions in BetaShares Nasdaq 100 ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Apple, Berkshire Hathaway, BetaShares Nasdaq 100 ETF, Meta Platforms, Microsoft, Nike, Nvidia, Tesla, and Walt Disney. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended the following options: long January 2025 $47.50 calls on Nike, long January 2026 $395 calls on Microsoft, and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has recommended Apple, Berkshire Hathaway, Meta Platforms, Microsoft, Nike, Nvidia, VanEck Morningstar Wide Moat ETF, and Walt Disney. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.